Project-specific health-based exposure limit and occupational toxicology assessment support. The agreed scope may include PDE/ADE derivation, OEL derivation and OEB/OHC banding, based on the exact substance form, available evidence and intended product or workplace context.
CAS Registry Number
58186-27-9
Molecular formula
C19H30O5
Molecular weight
338.44 g/mol
Drug class
Synthetic benzoquinonemitochondrial electron-transfer agent and antioxidant
Mechanism of action
A short-chain benzoquinone that can transfer electrons directly to complex III of the mitochondrial electron-transport chain, bypassing defective complex I and supporting cellular ATP generation under conditions of complex I dysfunction. It also has antioxidant activity.
Indications / reported uses
Treatment of visual impairment in adolescents and adults with Leber’s hereditary optic neuropathy (LHON), within the authorised product indication.
Scope is agreed for the exact substance form, intended use, exposure route, workplace context and available toxicological evidence.
PDE/ADE: critical effects, point of departure and justified adjustment factors.
OEL: inhalation hazards, exposure duration and workplace conditions.
OEB/OHC: evidence-based banding where requested; a band is not a numerical OEL.
Report: scientific rationale, source data, assumptions, uncertainties and limitations.
Assessment scope
PDE/ADE and OEL/OEB assessment
ReguSight provides project-specific support for Idebenone PDE/ADE, OEL and OEB/OHC assessments. This combined profile covers the Idebenone Permitted Daily Exposure (PDE) report (the Idebenone PDE report); Acceptable Daily Exposure (ADE) is the corresponding health-based daily exposure terminology. It also covers the Idebenone Occupational Exposure Limit (OEL) report (the Idebenone OEL report). PDE/ADE derivation and workplace exposure assessment are distinct scientific outputs; a band is not a numerical OEL.
Assessment may cover
PDE/ADE derivation using relevant toxicological evidence, critical effects, a justified point of departure and adjustment factors.
The EMA HBEL guideline informs PDE/ADE assessments in relevant shared-facility contexts. ECHA and HSE sources address workplace exposure limits; NIOSH provides occupational exposure-banding guidance. The applicable framework depends on the assessment question and jurisdiction.